Ana Carolina Migliorini Figueira
Lider Researcher, Advanced Cluster in Tissue ENginerring – NuTET /
Advanced Cluster in Helth Technologies – NATS / Laboratorio Nacional de Biociências -LNBio – CNPEM
BrazMedChem 2025 back to
Rio de Janeiro after 9 years
XII BrazMedChem 2025 – 20-24th september
Búzios Rio de Janeiro – Brazil
Medicinal Chemistry: rescuing the empowerment of science to promote human health.
Presentation
Theme: “Medicinal Chemistry: rescuing the empowerment of science to promote human health”
Aiming to organize a scientifically
Memorable event against the magnificent natural scenes of RJ (which few places in the world can rival)
Promote social interactions
Pleasant and culturally stimulating environment
Bring together
A large number of internationally renowned scientists
Facilitate access
Facilitate access to students and researchers from all regions of Brazil
Language
The official language of BrazMedChem2025 is English
Official hotel
Hotel Atlântico, Búzios-RJ https://www.atlanticobuzios.com.br/
Speakers
Ashvani Singh
Senior Principal Research Scientist, Abbvie, USA
“Discovery and Development of CFTR Modulators for the Treatment of Cystic Fibrosis”
Carlos A. Grabois Gadelha
Desenvolvimento Sustentável, CT&I e Complexo Econômico-Industrial da Saúde (CEE/ENSP–Fiocruz/MS).
“”
Dr Yuhong Du
Emory University, Atlanta, GA, USA
“Connecting Biology to Chemistry through High Throughput Screening”
Dr. André Silva Pimentel
PUC-Rio
“Explainable Artificial Intelligence for the Design of Novel Anticancer RNA- and Peptide-Based Therapeutics”
Dr. Andrea Diniz
Universidade Estadual de Maringá
“From Concept to Practice: The Contribution of PBPK Modeling in Early Drug Development”
Dr. Bahne Stechmann
Deputy Director
EU-OPENSCREEN ERIC
“Putting your compounds to good use: EU-OPENSCREEN’s open compound sharing initiative”
Dr. Damian W. Young
Baylor College of Medicine, USA
“Using DNA-Encoded Libraries for Drug Discovery in Academia”
Dr. Daniel A. Harki
University of Minnesota
“3′-Deoxy-3′,4′-didehydro-nucleosides and ProTides as Potent Antiviral Agents”
Dr. Didier Rognan
University of Strasbourg
“Reaction-driven generation of bioactive compounds from ultra-large chemical spaces”
Dr. Francesco Gentile
Ottawa Institute of Systems Biology, University of Ottawa
“Synergizing Computational Chemistry and AI for Early-Stage Drug Discovery”
Dr. Lars Zender
Universität Tubingen – Tübingen / Germany
“Development and Characterization of Kinase sparing Aurora Kinase A Ligands for improved Cancer Therapy”
Dr. Marina Melchiors, Ph.D.
Customer Success Specialist, CAS
“ACS on CAMPUS”
Dr. Matthias Gehringer, Ph.D.
Full Professor (W3), Eberhard Karls Universität Tübingen
“ACS on CAMPUS”
Dr. Paul C. Trippier
University of Nebraska
“Optimization of Neurolysin Activators as Potential Therapeutic Options in Ischemic Stroke”
Dr. Silvana Leit
Executive Director, Nimbus Therapeutics. US
“Discovery of NTX-801, a potent Cbl-b inhibitor with antitumor activity in syngeneic models”
Dr. Stefan Knapp
Johann Wolfgang Goethe-University
“Targeting new E3 Ligases and validating them for PROTAC development”
Hátylas Azevedo
Aché Laboratórios
“Exploring R&D Synergies in Natural Products, Small Molecules and Enabling Drug Technologies”
James Duffy
Medicines for Malaria Venture
“Replenishing the malaria drug discovery pipeline: Advances in Hit Generation for Antimalarial Drug Discovery”
Katlin Brauer Massirer
Researcher at the Center for Molecular Biology and Genetics at Unicamp, coordinator of the Medicinal Chemistry Laboratory
“Deconvoluting RNA Binding proteins as drug targets, by chromatography-based chemical fragment screening”
Luc Van Hijfte
EFMC/Novalix
“My 4 decades journey in Pharma : riding the wave of change”
Luis Eduardo Reina Gamba
Head of Medicinal Chemistry – Drug Discovery, Eurofarma.
“Drug Discovery at Eurofarma Laboratórios”
Maria Augusta Arruda
Brazilian National Centre for Research in Energy and Materials (LNBIO-CNPEM)
“Sustainable and Responsible Radical Innovation in Health: the CNPEM experience”
Mark Brönstrup
Chemische Biologie (CBIO)
HZI – Helmholtz-Zentrum für Infektionsforschung GmbH
“Assault, Siege, Trojan Horses or Gentle Disarmament: Four Molecular Strategies to Fight Bacterial Infections”
Prof. Dr. Stefan Wölfl
University of Heidelberg
“Microfluidic “organ-on-a-chip” tissue culture model systems
for drug testing and toxicity studies”
Prof. Emeritus Ronald J. Quinn
AM, FTSE – Griffith University
“Approaches for Natural Product Drug Discovery from compound libraries to Hit Identification”
Prof. Laurent E. Dardenne
Laboratório Nacional de Computação Científica – MCTI
“Using Generative AI for Many-Objective Small-Molecule Design”
Prof. Susan Wyllie
Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee
“The direct approach: the role of chemical proteomics in drug target deconvolution”
Professor Tricia Naicker (PhD)
University of KwaZulu-Natal
“In Vitro and In Vivo Development of β-Lactam-Metallo-β-Lactamase Inhibitors: Targeting Carbapenem-Resistant Enterobacterales”
Rui Ferreira Alves Moreira
Universidade de Lisboa
“Discovery and Optimization of Small-Molecule Tools Targeting Necroptosis Cell Death”
More Information
The official language of BrazMedChem2025 is English. All abstracts and panels should be written in English. The official language of Brazil is Portuguese.
Official hotel: Atlântico Búzios Convention, Búzios-RJ
- Room rates:
- Single
- Double
- Triple
- For booking contact: Creacteve Eventos | creacteve@creacteve.com.br | WhatsApp: + 55 21 99557 0582
Check the link for exclusive values for the event.
Accommodations Info
Reservations at the Hotel Atlântico Buzios can be made online here.
We advise you to book accommodation as soon as possible, as availability is limited.
Hotel Atlantico Buzios
The Hotel Atlântico Buzios Convention is located in the town of Armação dos Búzios, 166 km from Rio de Janeiro. Situated on Armação Beach, and surrounded by a unique natural landscape.
With a privileged location, with exits to Orla Bardot, from the hotel you can easily reach Rua das Pedras and some of the city’s most charming beaches.
Organizing Committee
- Dr. Floriano Paes Silva Junior – Chair (FIOCRUZ, Rio de Janeiro-RJ)
- Dra. Lídia Moreira Lima – Chair (UFRJ, Rio de Janeiro-RJ)
- Dr. Arthur Kummerle (UFRRJ, Rio de Janeiro-RJ)
- Dr. Carlos Maurício (UFRRJ, Rio de Janeiro-RJ)
- Dra. Luzineide Tinoco (UFRJ, Rio de Janeiro-RJ)
- Dra. Sabrina Ferreira (UFRJ, Rio de Janeiro-RJ)
Scientific Committee
- Glaucius Oliva – USP, São Carlos-SP (President)
- Rafael Guido – USP, São Carlos-SP (President)
International
- Stefan Laufer, President of DPhG and Chairman Pharmaceutical / Medicinal Chemistry (Institute of Pharmacy), Germany (Coordinator)
- Anna Juncker, Vice President of DPhG, Werner Siemens Imaging Center, Germany
- Luc Van Hijfte, Novalix, Senior advisor Drug Discovery, France
- Gunda Georg, Chairwoman MedChem Division ACS, USA
- Maria Laura Bolognesi, University of Bologna, Italy
- Jean Quancard, Chairman Best Practice Working Group of EFMC, Novartis, Switzerland
Brazilian
- Andrei Leitão – University of São Paulo at São Carlos
- Ângelo de Fátima – Federal University of Minas Gerais
- Claudio Viegas Jr – Federal University of Alfenas
- Christiano Guimarães – Nintx – Next Innovative Therapeutics
- Daniela Barretto Barbosa Trivella – Biosciences National Laboratory
- Fernanda Guilhon Simplicio – Federal Univesity of Amazonas
- Flavio da Silva Emery – University of São Paulo at Ribeirão Preto
- Gustavo Trossini – University of São Paulo
- Hugo Verli – Federal University of Rio Grande do Sul
- Isabella Alvim Guedes – National Laboratory of Scientific Computing
- Jean Leandro dos Santos – São Paulo State University
- João Paulo S. Fernandes – Federal University of São Paulo
- Luiz Carlos Dias – Campinas State University
- Luis Octavio Regasini – State University of São Paulo
- Magaly Girão Albuquerque – Federal University of Rio de Faneiro
- Marcela Cristina de Moraes – Fluminense Federal University
- Marcelo Santos Castilho – Federal University of Bahia
- Marco Edilson Freire de Lima – Federal Rural University of Rio de Faneiro
- Maria Cristina Nonato – University of São Paulo at Ribeirão Preto
- Marilia Valli – University of São Paulo at Ribeirão Preto
- Nailton M. Nascimento Júnior – State University of São Paulo
- Nubia Boechat – Oswaldo Cruz Foundation
- Rafaela Salgado Ferreira – Federal University of Minas Gerais
- Vitor Francisco Ferreira – Fluminense Federal University
Secretariat
Creacteve Eventos creacteve@creacteve.com.br
WhatsApp + 55 21 99557 0582
Registration
Accessing registration systems
Special conditions for students!
More information for the application process here
Visa
Visas to enter Brazil are granted by the Brazilian consulates abroad. Citizens of countries that are members of the Mercosul do not require visas, only a valid passport or valid identity document are required.
To learn more about the documentation and procedures for granting visas, see the Brazilian embassy/consulate in your country of origin.
Also check out here for further information on Brazilian Visa.
Citizens travelling with passports from Australia, Canada and the United States visiting Brazil for tourism and business will be subject to visa requirements for entry into Brazilian territory starting from April 10th, 2024. These citizens can require e-Visas through the portal https://brazil.vfsevisa.com/. The process is easy, and quick and if the requirements mentioned below are met, in a few days the applicant will receive the e-Visa on his or her e-mail.
